IL-PROTEINTECH-GROUP
Proteintech Group, a leading manufacturer of antibodies and related products, is celebrating the 20th anniversary of its founding. To celebrate the achievements and challenges of the past years, Proteintech will host special events throughout the year with its customers, collaborators, and employees while still looking forward to future opportunities.
“Over the years we have witnessed countless discoveries and we couldn’t be prouder of everything our customers have achieved. We want to thank all of our customer for their tireless efforts and sacrifices to advance scientific discovery,” Dr. Jason Li, CEO
Proteintech Group was founded in early 2001 by a small group of scientists including its current CEO, Dr. Jason Li. The founders set out with a vision to produce an antibody for every single protein coded in the human genome. Comprehensive coverage of all human gene products is a massive undertaking, but critical because it is difficult for researchers to predict which targets may be required to further scientific studies. With antibodies for two-thirds of the human genome, Proteintech has the largest self-manufactured target coverage of all antibody companies.
100,000 success stories to date
“While we are proud of our progress as a company over the past couple decades, we are most proud of what our technology has done in the hands of scientists. We’ve seen more than 100,000 citations of our products since our company establishment,” said Dr. Li. “We are excited about the future and how we can continue to help scientists apply the new technology we are working on to help people.”
Company expansion and cGMP facility
As Proteintech has continued to expand their own antibody, protein and ELISA kit product lines, they have welcomed other producers of high-quality tool providers for scientists. In April 2018, Proteintech acquired Humanzyme™, a Chicago-based manufacturer of human cell-expressed proteins, and shortly thereafter opened their cGMP facility in 2019. Using a proprietary HEK293 cell expression technology, HumanKine™ proteins are authentic human proteins with human glycosylation providing an optimized biological activity. Furthermore, they can be easily transferred from research grade, preclinical and process development to GMP grade for manufacturing in clinical trials and for commercial products.
In 2020, Proteintech acquired ChromoTek, a Munich-based manufacturer of camelid, single-domain antibodies, also known as nanobodies. These high-performance recombinant reagents will help Proteintech address opportunities and challenges in single cell analysis, super resolution imaging, and multiplex assays.
Over the last 20 years, Proteintech has grown in their global reach. With locations in the US, UK, Germany, Singapore, China and Japan, Proteintech is able to provide fast delivery around the world. Now with over 300 employees worldwide, Proteintech is setting their sights on continuing to support the future of science with quality, transparency, and customer needs in mind.
For more information on Proteintech and their products please visit ptglab.com. For the event page please visit ptglab.com/news/company-news/celebrating-our-20th-anniversary .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210615005887/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Venture Global Statement on CP2 Final Approval22.10.2025 16:33:00 CEST | Press release
The U.S. Department of Energy issued the final non-FTA export authorization for Venture Global’s CP2 facility in Cameron Parish, Louisiana. Venture Global CEO Mike Sabel issued the following statement: “Venture Global is grateful for the Trump Administration’s final approval of CP2, a critical project that will supply American allies with low-cost LNG for decades, support thousands of jobs and greatly benefit the U.S. balance of trade. The CP2 project construction is well underway and we look forward to continue advancing the project safely and quickly to bring new LNG to the global market at a record pace beginning in 2027.” About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (LNG) with over 100 MTPA of capacity in production, construction, or development. Venture Global began producing LNG from its first facility in 2022 and is now one of the largest LNG exporters in the United States. The company’s vertically integrated bus
British Arab Commercial Bank Partners With Volante Technologies to Modernize Payments Infrastructure With PaaS22.10.2025 15:38:00 CEST | Press release
Volante’s cloud-native platform to unify BACB’s payment operations across SWIFT, CHAPS, Faster Payments, BACS, and more Volante Technologies, the global leader in Payments as a Service (PaaS), today announced a new partnership with British Arab Commercial Bank (BACB), to modernize the bank’s payment processing infrastructure and replace legacy systems with a cloud-native platform. BACB will use Volante’s PaaS solution to automate and streamline the entirety of its payments volumes across multiple payment schemes, including SWIFT MT/ISO 20022, CHAPS, Faster Payments, BACS, and internal transfers. Volante’s solution enables BACB to move beyond legacy systems and manual processes, empowering the bank to raise straight-through processing rates and continue to provide a first-class service to its customers. BACB is an international wholesale bank, with $4.4 billion in assets, who provide a range of trade solutions to clients trading in and out of developing markets, across Africa and the Mi
Qualcomm Schedules Fourth Quarter and Fiscal 2025 Earnings Release and Conference Call22.10.2025 15:00:00 CEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced that it will publish the Company’s financial results for its fourth quarter and fiscal 2025 on Wednesday, November 5, 2025, after the close of the market on the Company’s Investor Relations website, at https://investor.qualcomm.com/financial-information. The earnings release will also be furnished to the Securities and Exchange Commission (SEC) on a Form 8-K, which will be available on the SEC website at http://www.sec.gov. Qualcomm will host a conference call to discuss its fourth quarter and fiscal 2025 results which will be broadcast live on November 5, 2025, beginning at 1:45 p.m. Pacific Time (PT) at https://investor.qualcomm.com/news-events/investor-events/default.aspx. An audio replay will be available at https://investor.qualcomm.com/news-events/investor-events/default.aspx and via telephone following the live call for 30 days thereafter. To listen to the replay via telephone, U.S. callers may dial (877) 660-6853 and internat
XPRIZE and Avanci Launch Partnership to Provide Innovators with IP and Licensing Expertise22.10.2025 15:00:00 CEST | Press release
Collaboration ensures innovators benefit from critical resources to protect and advance breakthrough solutions XPRIZE, the world’s leader in designing and operating incentive competitions to solve humanity’s greatest challenges, and Avanci, the independent global leader in one-stop IP licensing platforms, today announced a partnership to empower XPRIZE innovators. For more than three decades, XPRIZE competitions have ignited bold solutions that ripple far beyond the competition itself to transform industries, inspire new technologies, and build an extraordinary global ecosystem of innovators dedicated to problem solving. This partnership with Avanci ensures that XPRIZE teams and alumni have access to the expertise and resources they need to protect, scale, and amplify their impact in the real world through access to Avanci’s expertise and experience in intellectual property (IP) protection and licensing. Tailored support from Avanci will help those entrepreneurs protect their breakthro
Cyclic Materials and VACUUMSCHMELZE Expand Partnership to Recycle Rare Earth Magnet Manufacturing Waste in the U.S.22.10.2025 15:00:00 CEST | Press release
Cyclic Materials, the advanced recycling company creating a circular supply chain for rare earth elements (REEs) and other critical materials, today announced an expansion of its partnership with VACUUMSCHMELZE (VAC), a leading developer of magnetic materials and solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251022335302/en/ The companies have signed a 10-year exclusive agreement for recycling 100 percent of the magnet production byproducts (i.e. swarf) that will be produced at VAC's impressive new manufacturing facility in Sumter, South Carolina scheduled to begin operations at the end of 2025. This extended partnership builds on the 2024 agreement between both companies that ensures efficient recycling of critical materials used in high-performance permanent magnets. "At Cyclic Materials, our mission is to recover critical materials from permanent magnets that can be put back into the magnet supply chain to red
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom